Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 17, Issue 11, Pages 1327-1343
Publisher
Informa UK Limited
Online
2021-11-03
DOI
10.1080/17425255.2021.1999410
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA‐122 and cytokeratin‐18 have potential as a biomarkers of drug‐induced liver injury in European and African patients on treatment for mycobacterial infection
- (2021) Sarah A.E. Rupprechter et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Incidence and risk factors of anti‐tuberculosis drug induced liver injury (DILI): Large cohort study involving 4652 Chinese adult tuberculosis patients
- (2021) Fanrong Jiang et al. LIVER INTERNATIONAL
- The hepatotoxicity of Polygonum multiflorum: The emerging role of the immune-mediated liver injury
- (2020) Tai Rao et al. ACTA PHARMACOLOGICA SINICA
- Metabolomics Profiling and Diagnosis Biomarkers Searching for Drug-Induced Liver Injury Implicated to Polygonum multiflorum: A Cross-Sectional Cohort Study
- (2020) Ying Huang et al. Frontiers in Medicine
- EASL Clinical Practice Guidelines: Drug-induced liver injury
- (2019) Raúl Andrade et al. JOURNAL OF HEPATOLOGY
- Incidence and Etiology of Drug-Induced Liver Injury in Mainland China
- (2019) Tao Shen et al. GASTROENTEROLOGY
- Tools for causality assessment in drug-induced liver disease
- (2019) Hans L. Tillmann et al. CURRENT OPINION IN GASTROENTEROLOGY
- Metabolomics and Cytokine Analysis for Identification of Severe Drug-Induced Liver Injury
- (2019) Zhongyang Xie et al. JOURNAL OF PROTEOME RESEARCH
- Next Generation DILI Biomarkers: Prioritization of Biomarkers for Qualification and Best Practices for Biospecimen Collection in Drug Development
- (2019) Sharin E. Roth et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Serum metabolome and targeted bile acid profiling reveals potential novel biomarkers for drug-induced liver injury
- (2019) Zhenhua Ma et al. MEDICINE
- Risk profiling using metabolomic characteristics for susceptible individuals of drug-induced liver injury caused by Polygonum multiflorum
- (2019) Le Zhang et al. ARCHIVES OF TOXICOLOGY
- Development and Validation of a Test to Identify Drugs That Cause Idiosyncratic Drug-Induced Liver Injury
- (2018) Andreas Benesic et al. Clinical Gastroenterology and Hepatology
- Reply
- (2018) Rachel J. Church et al. HEPATOLOGY
- New biomarkers for drug-induced liver injury
- (2018) James W. Dear HEPATOLOGY
- Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort
- (2018) Rachel J. Church et al. HEPATOLOGY
- Pharmacogenomics of drug-induced liver injury (DILI): Molecular biology to clinical applications
- (2018) Kalaiyarasi Kaliyaperumal et al. JOURNAL OF HEPATOLOGY
- Proteomics Analysis of Monocyte-Derived Hepatocyte-Like Cells Identifies Integrin Beta 3 as a Specific Biomarker for Drug-Induced Liver Injury by Diclofenac
- (2018) Diana Dragoi et al. Frontiers in Pharmacology
- Cytokine profiles in acute liver injury—Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group
- (2018) Herbert L. Bonkovsky et al. PLoS One
- Drug-induced liver injury: recent advances in diagnosis and risk assessment
- (2017) Gerd A Kullak-Ublick et al. GUT
- Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recovery
- (2017) Valentina Peta et al. PLoS One
- Profiles of miRNAs in serum in severe acute drug induced liver injury and their prognostic significance
- (2016) Mark W. Russo et al. LIVER INTERNATIONAL
- Liver Damage Associated withPolygonum multiflorumThunb.: A Systematic Review of Case Reports and Case Series
- (2015) Xiang Lei et al. Evidence-based Complementary and Alternative Medicine
- Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study
- (2015) Naga Chalasani et al. GASTROENTEROLOGY
- Pharmacogenetic testing in idiosyncratic drug-induced liver injury: current role in clinical practice
- (2015) Guruprasad P. Aithal LIVER INTERNATIONAL
- Benign elevations in serum aminotransferases and biomarkers of hepatotoxicity in healthy volunteers treated with cholestyramine
- (2014) Rohit Singhal et al. BMC Pharmacology & Toxicology
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
- (2013) Penny F. Whiting ANNALS OF INTERNAL MEDICINE
- Incidence, Presentation, and Outcomes in Patients With Drug-Induced Liver Injury in the General Population of Iceland
- (2013) Einar S. Björnsson et al. GASTROENTEROLOGY
- Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts
- (2013) Petra Thulin et al. LIVER INTERNATIONAL
- Profiles of Serum Cytokines in Acute Drug-Induced Liver Injury and Their Prognostic Significance
- (2013) Nury M. Steuerwald et al. PLoS One
- Serum proteomic profiling in patients with drug-induced liver injury
- (2012) L. N. Bell et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The Effects of Heparins on the Liver: Application of Mechanistic Serum Biomarkers in a Randomized Study in Healthy Volunteers
- (2012) A H Harrill et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Real Time Identification of Drug-Induced Liver Injury (DILI) through Daily Screening of ALT Results: A Prospective Pilot Cohort Study
- (2012) Helmi M'Kada et al. PLoS One
- Handsearching did not yield additional unique FDG-PET diagnostic test accuracy studies compared with electronic searches: a preliminary investigation
- (2012) Julie Glanville et al. Research Synthesis Methods
- Case Definition and Phenotype Standardization in Drug-Induced Liver Injury
- (2011) G P Aithal et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Serum metabolomics reveals γ-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease
- (2011) Tomoyoshi Soga et al. JOURNAL OF HEPATOLOGY
- Drug-Induced Liver Injury Network (DILIN) Prospective Study
- (2009) Robert J. Fontana et al. DRUG SAFETY
- HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
- (2009) Ann K Daly et al. NATURE GENETICS
- The importance of immune dysfunction in determining outcome in acute liver failure
- (2008) Charalambos Gustav Antoniades et al. JOURNAL OF HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started